HSA — authorised 19 August 1974
- Marketing authorisation holder: APOTHECON
- Status: likely_approved
HSA authorised Cefradex on 19 August 1974
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 19 August 1974.
APOTHECON holds the Singaporean marketing authorisation.